Page 218 - EJMO-9-2
P. 218

Eurasian Journal of
            Medicine and Oncology                                             Tetramethyl thyroxine boosts bladder cancer



               doi: 10.3322/caac.21834                            doi: 10.1002/1878-0261.13360
            2.   Starek-Świechowicz B, Budziszewska B, Starek A.   13.  Lotan Y, Raman JD, Konety B,  et  al. Urinary analysis of
               Endogenous estrogens-breast cancer and chemoprevention.   FGFR3  and TERT gene  mutations enhances performance
               Pharmacol Rep. 2021;73(6):1497-1512.               of Cxbladder tests and improves patient risk stratification.
                                                                  J Urol. 2023;209(4):762-772.
               doi: 10.1007/s43440-021-00317-0
                                                                  doi: 10.1097/ju.0000000000003126
            3.   Dai C, Dehm SM, Sharifi N. Targeting the androgen signaling
               axis in prostate cancer. J Clin Oncol. 2023;41(26):4267-4278.  14.  Ma Z, Li X, Mao Y, et al. Interferon-dependent SLC14A1
                                                                                                             +
                                                                  cancer-associated fibroblasts promote cancer stemness via
               doi: 10.1200/jco.23.00433
                                                                  WNT5A in bladder cancer. Cancer Cell. 2022;40(12):1550-
            4.   Croft PR, Lathrop SL, Feddersen RM, Joste NE. Estrogen   1565.e7.
               receptor expression in papillary urothelial carcinoma of the
               bladder and ovarian transitional cell carcinoma. Arch Pathol      doi: 10.1016/j.ccell.2022.11.005
               Lab Med. 2005;129(2):194-199.                   15.  Yu D, Geng H, Liu Z,  et al. Cigarette smoke induced
                                                                  urocystic epithelial mesenchymal transition via MAPK
               doi: 10.5858/2005-129-194-ereipu
                                                                  pathways. Oncotarget. 2017;8(5):8791-8800.
            5.   Ding M, Zhan H, Liao X, et al. Enhancer RNA - P2RY2e
               induced by estrogen promotes malignant behaviors of      doi: 10.18632/oncotarget.14456
               bladder cancer. Int J Biol Sci. 2018;14(10):1268-1276.  16.  Liu W, Shen D, Ju L, et al. MYBL2 promotes proliferation
                                                                  and metastasis of bladder cancer through transactivation of
               doi: 10.7150/ijbs.27151
                                                                  CDCA3. Oncogene. 2022;41(41):4606-4617.
            6.   Wolpert BJ, Amr S, Ezzat S,  et al. Estrogen exposure
               and bladder cancer  risk in Egyptian women.  Maturitas.      doi: 10.1038/s41388-022-02456-x
               2010;67(4):353-357.                             17.  Yang E, Jing S, Wang F,  et al. Mesenchymal stem cells
                                                                  in tumor microenvironment: Drivers of bladder cancer
               doi: 10.1016/j.maturitas.2010.07.014
                                                                  progression through mitochondrial dynamics and energy
            7.   Khan SR, Chaker L, Ruiter R, et al. Thyroid function and   production. Cell Death Dis. 2024;15(9):688.
               cancer risk: The Rotterdam study. J Clin Endocrinol Metab.
               2016;101(12):5030-5036.                            doi: 10.1038/s41419-024-07068-9
                                                               18.  Liu YC, Yeh CT, Lin KH. Molecular functions of thyroid
               doi: 10.1210/jc.2016-2104
                                                                  hormone signaling in regulation of cancer progression and
            8.   Wang Z, Rixiati Y, Jia C,  et al. Causal effect of thyroid   anti-apoptosis. Int J Mol Sci. 2019;20(20):4986.
               cancer on secondary primary malignancies: Findings from
               the UK Biobank and FinnGen cohorts.  Front Immunol.      doi: 10.3390/ijms20204986
               2024;15:1434737.                                19.  Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of
                                                                  metabolism. Physiol Rev. 2014;94(2):355-382.
               doi: 10.3389/fimmu.2024.1434737
                                                                  doi: 10.1152/physrev.00030.2013
            9.   Pierantoni F, Dionese M, Basso U,  et al. The prognostic
               value of thyroid hormone levels in immunotherapy-  20.  Gouveia CHA, Miranda-Rodrigues M, Martins GM, Neofiti-
               treated patients with metastatic urothelial carcinoma. Clin   Papi B. Thyroid hormone and skeletal development. Vitam
               Genitourin Cancer. 2023;21(5):e378-e385.           Horm. 2018;106:383-472.
               doi: 10.1016/j.clgc.2023.04.006                    doi: 10.1016/bs.vh.2017.06.002
            10.  Wang T, Xia L, Ma S, et al. Hepatocellular carcinoma: Thyroid   21.  Baksi S, Pradhan A. Thyroid hormone: Sex-dependent role
               hormone promotes tumorigenicity through inducing cancer   in nervous system regulation and disease. Biol Sex Differ.
               stem-like cell self-renewal. Sci Rep. 2016;6:25183.  2021;12(1):25.
               doi: 10.1038/srep25183                             doi: 10.1186/s13293-021-00367-2
            11.  Johnson JL, Felicetta JV. Hyperthyroidism: A comprehensive   22.  Jing L, Zhang Q. Intrathyroidal feedforward and feedback
               review. J Am Acad Nurse Pract. 1992;4(1):8-14.     network regulating thyroid hormone synthesis and
                                                                  secretion. Front Endocrinol (Lausanne). 2022;13:992883.
               doi: 10.1111/j.1745-7599.1992.tb01105.x
                                                                  doi: 10.3389/fendo.2022.992883
            12.  Zhang B, Jia P, Wang J, et al. Integrated analysis of racial
               disparities  in  genomic  architecture  identifies  a trans-  23.  Gauthier BR, Sola-García A, Cáliz-Molina M, et al. Thyroid
               ancestry prognostic subtype in bladder cancer. Mol Oncol.   hormones in  diabetes, cancer, and aging.  Aging Cell.
               2023;17(4):564-581.                                2020;19(11):e13260.




            Volume 9 Issue 2 (2025)                        210                         doi: 10.36922/EJMO025080037
   213   214   215   216   217   218   219   220   221   222   223